Sustainability

We are building a future where people’s health, community well-being, and planet protection are at the heart of our work, driven by innovation and strong business ethics. This is our vision of responsible business.
OUR WAY OF DOING BUSINESS. For over 100 years, we have had a steady presence in European healthcare. We have developed and made available innovative medicines and therapeutic solutions to improve people's quality of life and contribute to positive societal change. Sustainability is a cornerstone of our values and our approach to responsible business: we fully embrace the Angelini Industries Group's purpose of Unwavering care, which encapsulates our commitment and responsibility toward people and the world we live in.
OUR SUSTAINABILITY JOURNEY: At Angelini Pharma, we are committed to caring for people, the community, and the planet. We work alongside our partners, exploring innovative solutions with a focus on environmental and social sustainability. In 2023, we developed an ESG Plan that is now fully aligned with Angelini Industries' 2024-2026 Sustainability Plan. Through a double materiality analysis, we have translated our company’s and stakeholders’ intentions into a structured strategy, consistent with the Group's, setting a series of concrete goals.

Sustainability Plan
Our strategy is built on four pillars — Planet, People, Patients and Communities, Ecosystems — and two enabling factors — Product and Innovation, Governance — where we aim to focus our efforts in the coming years.
The targets of the plan are structured into four areas of action, aligned with the Group's ESG strategy pillars: People, Patients - Clients and Community, Ecosystems, Planet. These four pillars are represented as interconnected and interdependent concentric circles. Enabling factors for the realization of the ESG Plan are Good Governance and Innovation.
The pillars and enabling factors
Our goals
-
People
Wellbeing
Engagement Rate ≥ 75
-
People
H&S
Zero serious injuries ambition for own employeers
-
People
Development
Training hours / employee > European sector average
-
Planet
Climate
100% renewable purchased electricity (Italy) -
People
Incentives
MBOs linked to ESG indicators for N-1 and N-2 managers responsible for functions impacted by Sustainability aspects and/or capable of making a specific contribution to the Company's ESG strategy. -
Patients, Clients & Community
Local Communities
+20% each year of employees volunteering for local communities
-
Planet
Climate
100% renewable purchased electricity (all Angelini Pharma) -
People, Patients, Clients & Communities
Local communities and Ecosystem
Be a recognized partner to promote transition to future skills and contribute to closing the knowledge gap in the italian system -
Patients, Clients & Community
Health awareness and access to care
Be an accelerator of awareness & de-stigmatization to unlock access to care -
Ecosystems
Partner with value chain
>90% strategic suppliers covered by Code of Conduct
-
Ecosystems
Embed responsible procurement
>90% strategic suppliers assessed
on ESG criteria (by 2027)
-
Planet
Climate
CDP A-lister on climate change
-
Planet
Climate
Reduce GHG emissions in line with Paris agreement -
Planet
Waste & circularity
-90% ind. waste to landfill -
Planet
Waste & circularity
100% new products rolled out / EcoDesign considerations -
People
Top Employer
Remain top employer in Italy and Europe and be part of top companies in Best Workplaces Europe
Our 2023 results
PLANET
First corporate carbon footprint mapping according to Greenhouse Gas Protocol standards
PEOPLE
Achievement of UNI/PdR 125:2022 Certification for gender equality in Italy.
Reaching a 50% female representation in the global workforce.
PATIENTS AND COMMUNITIES
Developed the Patient Access Framework.
Commitment to facilitating access to the best possible care for all individuals with mental health issues and epilepsy through the Headway project.
ECOSYSTEM
Expansion of collaborations with universities and research centers to strengthen R&D activities and develop projects like PharmaSea, which studies the impact of active pharmaceutical ingredients (APIs) on marine ecosystems

Sustainability report
Explore our sustainability reporting by reading our latest published report.
Our stories
Contacts
For further inquiries, please contact our sustainability team: